null Jesse Papenburg, MD, M.Sc.

Scientist, RI-MUHC, Glen site

Infectious Diseases and Immunity in Global Health Program

Centre for Outcomes Research and Evaluation

Assistant Professor, Department of Pediatrics, Faculty of Medicine and Health Sciences, McGill University

Department of Pediatrics, Division of Infectious Diseases, MUHC



influenza • respiratory syncytial virus (RSV) • children • epidemiology • diagnosis • COVID-19

Research Focus

My research focuses on the epidemiology, diagnosis, treatment, and prevention of severe viral lower respiratory tract infections in children. I actively engage in knowledge translation in my field by contributing to national and provincial guidelines on RSV immunoprophylaxis, influenza antiviral treatment, and SARS-CoV-2 diagnostics and treatment. I am also a voting member of Canada's National Advisory Committee on Immunization (NACI) and chair of NACI’s influenza working group.

Research initiative
Site investigator, and influenza and respiratory syncytial virus (RSV) data captain for Canada’s Immunization Monitoring Program ACTive (IMPACT) surveillance network.

Selected Publications

Click on Pubmed to see my current publications list

  • Bourdeau M, Vadlamudi NK, Bastien N, Embree J, Halperin SA, Jadavji T, Kazmi K, Langley JM, Lebel MH, Le Saux N, Moore D, Morris SK, Pernica JM, Robinson J, Sadarangani M, Bettinger JA, Papenburg J; Canadian Immunization Monitoring Program Active (IMPACT) Investigators. Pediatric RSV-Associated Hospitalizations Before and During the COVID-19 Pandemic. JAMA Netw Open. 2023 Oct 2;6(10):e2336863. PMID: 37792376.

  • Schober T, Morris SK, Bettinger JA, Bancej C, Burton C, Foo C, Halperin SA, Jadavji T, Kazmi K, Modler J, Sadarangani M, Papenburg J; Canadian Immunization Monitoring Program Active (IMPACT) Investigators. Outcomes of immunocompromised children hospitalized for Influenza, 2010-2021, the Canadian Immunization Monitoring Program Active (IMPACT). Clin Microbiol Infect. 2023 Jul;29(7):924-932. PMID: 37054913.

  • Papenburg J, Defoy I, Massé E, Caouette G, Lebel MH. Impact of the Withdrawal of Palivizumab Immunoprophylaxis on the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born at 33 to 35 Weeks' Gestational Age in the Province of Quebec, Canada: The RSV-Quebec Study. J Pediatric Infect Dis Soc. 2021 Apr 3;10(3):237-244. PMID: 32530035.

  • Burstein B, Plint AC, Papenburg J. Use of radiography in patients diagnosed as having acute bronchiolitis in US emergency departments, 2007-2015. JAMA. 2018 Oct;320(15):1598-1600. PMID: 30326115.

  • Merckx J, Wali R, Schiller I, Caya C, Gore G, Chartrand C, Dendukuri N, Papenburg J. Diagnostic accuracy of novel and traditional rapid tests for influenza infection compared to RT-PCR: systematic review and meta-analysis. Ann Intern Med. 2017 Sept 167(6): 394-409.